Evidence map›Paper›PMID 32636303›Full record

ArticleThe Journal of biological chemistry2020

Interleukin-6-mediated epigenetic control of the VEGFR2 gene induces disorganized angiogenesis in human breast tumors.

Mangala Hegde, Kanive Parashiva Guruprasad, Lingadakai Ramachandra, Kapaettu Satyamoorthy, Manjunath B Joshi

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Suppression of NGALR impedes TNBC cell survival, proliferation, invasion, and migration through Akt/mTOR and JAK/STAT3 pathway inhibition.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Blockade of IL-6 signaling alleviates atherosclerosis inNature cardiovascular research · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. 3D tumor angiogenesis models: recent advances and challenges.Journal of cancer research and clinical oncology · 2021
    Review
  16. Article
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mangala HegdeManipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, India.
Kanive Parashiva GuruprasadManipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, India.
Lingadakai RamachandraKasturba Medical College, Manipal Academy of Higher Education, Manipal, India.
Kapaettu SatyamoorthyManipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, India.
Manjunath B JoshiManipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, India. Electronic address: manjunath.joshi@manipal.edu.
Manipal Academy of Higher Education · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Disorganized vessels in the tumor vasculature lead to impaired perfusion, resulting in reduced accessibility to immune cells and chemotherapeutic drugs. In the breast tumor-stroma interplay, paracrine factors such as interleukin-6 (IL-6) often facilitate disordered angiogenesis. We show here that epigenetic mechanisms regulate the crosstalk between IL-6 and vascular endothelial growth factor receptor 2 (VEGFR2) signaling pathways in myoepithelial (CD10

Indexed as

Breast NeoplasmsEpigenesis, GeneticGene Expression Regulation, NeoplasticSignal TransductionFemaleHumansHuman Umbilical Vein Endothelial CellsInterleukin-6MCF-7 CellsNeoplasm ProteinsNeovascularization, PathologicVascular Endothelial Growth Factor Receptor-2IL6 protein, humanInterleukin-6KDR protein, humanNeoplasm ProteinsVascular Endothelial Growth Factor Receptor-2angiogenesisbreast cancerDNA methyltransferaseDNA methyltransferase 1 (DNMT1)epigeneticsgene regulation interleukin 6 (IL-6)IL-6myoepithelial cellssignal transductiontumor microenvironmentvascular endothelial growth factor receptor 2VEGFR2

Identifiers

PMID32636303
PMCPMC7443485
OpenAlexW3041137956

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.